Skip to main content
Erschienen in: Abdominal Radiology 10/2017

13.04.2017

Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging

verfasst von: Sung Mo Kim, Sang Soo Shin, Byung Chan Lee, Jin Woong Kim, Suk Hee Heo, Hyo Soon Lim, Yong Yeon Jeong

Erschienen in: Abdominal Radiology | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To prospectively compare multidetector-row CT (MDCT) and MR imaging (MRI) in the assessment of the ablative margin (AM) and index tumor immediately after radiofrequency (RF) ablation for hepatocellular carcinoma (HCC) and assess whether non-contrast MRI with limited sequences (T1- and T2-weighted imaging only) was superior to a conventional MDCT protocol.

Methods

A total of 33 consecutive patients with 42 HCCs were included in this study. Both MDCT and MR images were independently reviewed by two radiologists regarding the ability to visually discriminate between the AM and index tumor, and the AM status within ablation zones. The AM status was classified as AM-plus (AM completely surrounding the tumor), AM-zero (AM was partly discontinuous, without protrusion of the tumor), and AM-minus (AM was partly discontinuous, with protrusion of the tumor). During the follow-up period, the cumulative local tumor progression rates were analyzed using the Kaplan–Meier method and Cox proportional hazards model. To determine the added value of contrast-enhanced MR images, both reviewers separately evaluated the two sets (unenhanced and enhanced) of MR images.

Results

Visual discrimination between the AM and index tumor was possible in four (9.5%) and 34 (81%) of the 42 ablation zones using MDCT and MRI, respectively (p < 0.001). Thirty-eight and four cases were classified as AM-plus and AM-zero on MDCT images, respectively, whereas the ablation zones were categorized as AM-plus (n = 32), AM-zero (n = 9), and AM-minus (n = 1) when examining the MR images. The cumulative incidence of local tumor progression was significantly lower in cases with AM-plus on MRI (p = 0.007). Contrast-enhanced MRI had no added value for the assessment of the AM and index tumor.

Conclusion

MRI was superior to MDCT for the differential assessment of the AM and index tumor immediately after RF ablation for HCC. Non-contrast MRI was also superior to the conventional MDCT protocol.
Literatur
1.
Zurück zum Zitat Kim YS, Lim HK, Rhim H, et al. (2013) Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 58:89–97CrossRefPubMed Kim YS, Lim HK, Rhim H, et al. (2013) Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 58:89–97CrossRefPubMed
2.
Zurück zum Zitat Shiina S, Tateishi R, Arano T, et al. (2012) Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 107:569–577CrossRefPubMed Shiina S, Tateishi R, Arano T, et al. (2012) Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol 107:569–577CrossRefPubMed
3.
Zurück zum Zitat Giannini EG, Farinati F, Del Poggio P, et al. (2012) Ten-year outcome of radiofrequency thermal ablation for hepatocellular carcinoma: an Italian experience. Am J Gastroenterol 107:1588–1589CrossRefPubMed Giannini EG, Farinati F, Del Poggio P, et al. (2012) Ten-year outcome of radiofrequency thermal ablation for hepatocellular carcinoma: an Italian experience. Am J Gastroenterol 107:1588–1589CrossRefPubMed
4.
5.
Zurück zum Zitat Livraghi T, Meloni F, Di Stasi M, et al. (2008) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 47:82–89CrossRefPubMed Livraghi T, Meloni F, Di Stasi M, et al. (2008) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 47:82–89CrossRefPubMed
6.
Zurück zum Zitat Kim JW, Shin SS, Heo SH, et al. (2015) Ultrasound-guided percutaneous radiofrequency ablation of liver tumors: how we do it safely and completely. Korean J Radiol 16:1226–1239CrossRefPubMedPubMedCentral Kim JW, Shin SS, Heo SH, et al. (2015) Ultrasound-guided percutaneous radiofrequency ablation of liver tumors: how we do it safely and completely. Korean J Radiol 16:1226–1239CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Peng ZW, Zhang YJ, Chen MS, et al. (2008) Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma. Surg Oncol 17:23–31CrossRefPubMed Peng ZW, Zhang YJ, Chen MS, et al. (2008) Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma. Surg Oncol 17:23–31CrossRefPubMed
8.
Zurück zum Zitat Kei SK, Rhim H, Choi D, et al. (2008) Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am J Roentgenol 190:1544–1551CrossRefPubMed Kei SK, Rhim H, Choi D, et al. (2008) Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am J Roentgenol 190:1544–1551CrossRefPubMed
9.
Zurück zum Zitat Kim YS, Lee WJ, Rhim H, et al. (2010) The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (>2 and <5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 195:758–765CrossRefPubMed Kim YS, Lee WJ, Rhim H, et al. (2010) The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (>2 and <5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 195:758–765CrossRefPubMed
10.
Zurück zum Zitat Nakazawa T, Kokubu S, Shibuya A, et al. (2007) Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 188:480–488CrossRefPubMed Nakazawa T, Kokubu S, Shibuya A, et al. (2007) Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 188:480–488CrossRefPubMed
11.
Zurück zum Zitat Kim YS, Rhim H, Cho OK, Koh BH, Kim Y (2006) Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol 59:432–441CrossRefPubMed Kim YS, Rhim H, Cho OK, Koh BH, Kim Y (2006) Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol 59:432–441CrossRefPubMed
12.
Zurück zum Zitat Zhong-Zhen S, Kai L, Rong-Qin Z, et al. (2012) A feasibility study for determining ablative margin with 3D-CEUS-CT/MR image fusion after radiofrequency ablation of hepatocellular carcinoma. Ultraschall Med 33:E250–E255CrossRefPubMed Zhong-Zhen S, Kai L, Rong-Qin Z, et al. (2012) A feasibility study for determining ablative margin with 3D-CEUS-CT/MR image fusion after radiofrequency ablation of hepatocellular carcinoma. Ultraschall Med 33:E250–E255CrossRefPubMed
13.
Zurück zum Zitat Koda M, Tokunaga S, Okamoto T, et al. (2015) Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma. J Hepatol 63:1360–1367CrossRefPubMed Koda M, Tokunaga S, Okamoto T, et al. (2015) Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma. J Hepatol 63:1360–1367CrossRefPubMed
14.
Zurück zum Zitat Kim KW, Lee JM, Klotz E, et al. (2011) Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images. AJR Am J Roentgenol 196:W565–W572CrossRefPubMed Kim KW, Lee JM, Klotz E, et al. (2011) Safety margin assessment after radiofrequency ablation of the liver using registration of preprocedure and postprocedure CT images. AJR Am J Roentgenol 196:W565–W572CrossRefPubMed
15.
Zurück zum Zitat Bouda D, Lagadec M, Alba CG, et al. (2016) Imaging review of hepatocellular carcinoma after thermal ablation: the good, the bad, and the ugly. J Magn Reson Imaging 44:1070–1090CrossRefPubMed Bouda D, Lagadec M, Alba CG, et al. (2016) Imaging review of hepatocellular carcinoma after thermal ablation: the good, the bad, and the ugly. J Magn Reson Imaging 44:1070–1090CrossRefPubMed
16.
Zurück zum Zitat Motoyama T, Ogasawara S, Chiba T, et al. (2014) Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma. Abdom Imaging 39:262–268CrossRefPubMed Motoyama T, Ogasawara S, Chiba T, et al. (2014) Coronal reformatted CT images contribute to the precise evaluation of the radiofrequency ablative margin for hepatocellular carcinoma. Abdom Imaging 39:262–268CrossRefPubMed
17.
Zurück zum Zitat Koda M, Tokunaga S, Miyoshi K, et al. (2013) Ablative margin states by magnetic resonance imaging with ferucarbotran in radiofrequency ablation for hepatocellular carcinoma can predict local tumor progression. J Gastroenterol 48:1283–1292CrossRefPubMed Koda M, Tokunaga S, Miyoshi K, et al. (2013) Ablative margin states by magnetic resonance imaging with ferucarbotran in radiofrequency ablation for hepatocellular carcinoma can predict local tumor progression. J Gastroenterol 48:1283–1292CrossRefPubMed
18.
Zurück zum Zitat Koda M, Tokunaga S, Miyoshi K, et al. (2012) Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol 81:2730–2736CrossRefPubMed Koda M, Tokunaga S, Miyoshi K, et al. (2012) Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol 81:2730–2736CrossRefPubMed
19.
Zurück zum Zitat Koda M, Tokunaga S, Fujise Y, et al. (2012) Assessment of ablative margin after radiofrequency ablation for hepatocellular carcinoma; comparison between magnetic resonance imaging with ferucarbotran and enhanced CT with iodized oil deposition. Eur J Radiol 81:1400–1404CrossRefPubMed Koda M, Tokunaga S, Fujise Y, et al. (2012) Assessment of ablative margin after radiofrequency ablation for hepatocellular carcinoma; comparison between magnetic resonance imaging with ferucarbotran and enhanced CT with iodized oil deposition. Eur J Radiol 81:1400–1404CrossRefPubMed
20.
Zurück zum Zitat Yoon JH, Lee EJ, Cha SS, et al. (2010) Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas. J Vasc Interv Radiol 21:348–356CrossRefPubMed Yoon JH, Lee EJ, Cha SS, et al. (2010) Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas. J Vasc Interv Radiol 21:348–356CrossRefPubMed
21.
Zurück zum Zitat Mori K, Fukuda K, Asaoka H, et al. (2009) Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran–feasibility study. Radiology 251:557–565CrossRefPubMed Mori K, Fukuda K, Asaoka H, et al. (2009) Radiofrequency ablation of the liver: determination of ablative margin at MR imaging with impaired clearance of ferucarbotran–feasibility study. Radiology 251:557–565CrossRefPubMed
22.
Zurück zum Zitat Makino Y, Imai Y, Igura T, et al. (2015) Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma. Abdom Imaging 40:102–111CrossRefPubMed Makino Y, Imai Y, Igura T, et al. (2015) Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma. Abdom Imaging 40:102–111CrossRefPubMed
23.
Zurück zum Zitat Mitchell DG, Bruix J, Sherman M, Sirlin CB (2015) LI-RADS (liver imaging reporting and data System): summary, discussion, and consensus of the LI-RADS management working Group and future directions. Hepatology 61:1056–1065CrossRefPubMed Mitchell DG, Bruix J, Sherman M, Sirlin CB (2015) LI-RADS (liver imaging reporting and data System): summary, discussion, and consensus of the LI-RADS management working Group and future directions. Hepatology 61:1056–1065CrossRefPubMed
24.
Zurück zum Zitat Korean Liver Cancer Study Group, National Cancer Center Korea (2015) 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol 16:465–522CrossRef Korean Liver Cancer Study Group, National Cancer Center Korea (2015) 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol 16:465–522CrossRef
25.
Zurück zum Zitat Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology 272:635–654CrossRefPubMedPubMedCentral Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology 272:635–654CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 273:30–50CrossRefPubMedPubMedCentral Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 273:30–50CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Ahmed M, Solbiati L, Brace CL, et al. (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology 273:241–260CrossRefPubMedPubMedCentral Ahmed M, Solbiati L, Brace CL, et al. (2014) Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology 273:241–260CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Khankan AA, Murakami T, Onishi H, et al. (2008) Hepatocellular carcinoma treated with radio frequency ablation: an early evaluation with magnetic resonance imaging. J Magn Reson Imaging 27:546–551CrossRefPubMed Khankan AA, Murakami T, Onishi H, et al. (2008) Hepatocellular carcinoma treated with radio frequency ablation: an early evaluation with magnetic resonance imaging. J Magn Reson Imaging 27:546–551CrossRefPubMed
29.
Zurück zum Zitat Goldberg SN, Gazelle GS, Mueller PR (2000) Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 174:323–331CrossRefPubMed Goldberg SN, Gazelle GS, Mueller PR (2000) Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 174:323–331CrossRefPubMed
30.
Zurück zum Zitat Kim YS, Rhim H, Lim HK, et al. (2011) Coagulation necrosis induced by radiofrequency ablation in the liver: histopathologic and radiologic review of usual to extremely rare changes. Radiographics 31:377–390CrossRefPubMed Kim YS, Rhim H, Lim HK, et al. (2011) Coagulation necrosis induced by radiofrequency ablation in the liver: histopathologic and radiologic review of usual to extremely rare changes. Radiographics 31:377–390CrossRefPubMed
31.
Zurück zum Zitat Onishi H, Matsushita M, Murakami T, et al. (2004) MR appearances of radiofrequency thermal ablation region: histopathologic correlation with dog liver models and an autopsy case. Acad Radiol 11:1180–1189CrossRefPubMed Onishi H, Matsushita M, Murakami T, et al. (2004) MR appearances of radiofrequency thermal ablation region: histopathologic correlation with dog liver models and an autopsy case. Acad Radiol 11:1180–1189CrossRefPubMed
32.
Zurück zum Zitat Tsuda M, Rikimaru H, Majima K, et al. (2003) Time-related changes of radiofrequency ablation lesion in the normal rabbit liver: findings of magnetic resonance imaging and histopathology. Invest Radiol 38:525–531PubMed Tsuda M, Rikimaru H, Majima K, et al. (2003) Time-related changes of radiofrequency ablation lesion in the normal rabbit liver: findings of magnetic resonance imaging and histopathology. Invest Radiol 38:525–531PubMed
33.
Zurück zum Zitat Park Y, Choi D, Rhim H, et al. (2010) Central lower attenuating lesion in the ablation zone on immediate follow-up CT after percutaneous radiofrequency ablation for hepatocellular carcinoma: incidence and clinical significance. Eur J Radiol 75:391–396CrossRefPubMed Park Y, Choi D, Rhim H, et al. (2010) Central lower attenuating lesion in the ablation zone on immediate follow-up CT after percutaneous radiofrequency ablation for hepatocellular carcinoma: incidence and clinical significance. Eur J Radiol 75:391–396CrossRefPubMed
34.
Zurück zum Zitat Martin J, Sentis M, Zidan A, et al. (1995) Fatty metamorphosis of hepatocellular carcinoma: detection with chemical shift gradient-echo MR imaging. Radiology 195:125–130CrossRefPubMed Martin J, Sentis M, Zidan A, et al. (1995) Fatty metamorphosis of hepatocellular carcinoma: detection with chemical shift gradient-echo MR imaging. Radiology 195:125–130CrossRefPubMed
35.
Zurück zum Zitat Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M (2000) Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 33:282–289CrossRefPubMed Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M (2000) Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 33:282–289CrossRefPubMed
36.
Zurück zum Zitat Kadoya M, Matsui O, Takashima T, Nonomura A (1992) Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 183:819–825CrossRefPubMed Kadoya M, Matsui O, Takashima T, Nonomura A (1992) Hepatocellular carcinoma: correlation of MR imaging and histopathologic findings. Radiology 183:819–825CrossRefPubMed
Metadaten
Titel
Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging
verfasst von
Sung Mo Kim
Sang Soo Shin
Byung Chan Lee
Jin Woong Kim
Suk Hee Heo
Hyo Soon Lim
Yong Yeon Jeong
Publikationsdatum
13.04.2017
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 10/2017
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1146-z

Weitere Artikel der Ausgabe 10/2017

Abdominal Radiology 10/2017 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.